Copyright
©The Author(s) 2016.
World J Nephrol. Sep 6, 2016; 5(5): 471-481
Published online Sep 6, 2016. doi: 10.5527/wjn.v5.i5.471
Published online Sep 6, 2016. doi: 10.5527/wjn.v5.i5.471
Model | Covariates controlled for | Adjusted HR (95%CI) | P |
0 (Unadjusted) | 25-hydroxivitamin D levels (mg/dL) | 0.95 (0.91-0.99) | 0.009 |
1 | 25-hydroxivitamin D levels (mg/dL) + age | 0.95 (0.91-0.99) | 0.009 |
2 | Model 1 + diabetes mellitus, ischemic heart disease, chronic heart failure | 0.96 (0.92-0.99) | 0.028 |
3 | Model 1 + peripheral arterial disease, abnormal ABPI1, phosphorous (mg/dL) | 0.95 (0.92-0.99) | 0.023 |
4 | Model 1 + DBP (mm Hg), 1,25(OH)2 vitamin D (pg/mL), estimated GFR (mL/min per 1.73 m2) | 0.96 (0.92-0.99) | 0.020 |
5 | Model 1 + vascular calcification [Kauppila score (log), Adragao score (log)], CKD stage 5 | 0.95 (0.91-1.00) | 0.050 |
6 | Model 1 + obesity, hemoglobin (g/L), albumin (g/dL) | 0.95 (0.92-0.99) | 0.019 |
- Citation: Molina P, Górriz JL, Molina MD, Beltrán S, Vizcaíno B, Escudero V, Kanter J, Ávila AI, Bover J, Fernández E, Nieto J, Cigarrán S, Gruss E, Fernández-Juárez G, Martínez-Castelao A, Navarro-González JF, Romero R, Pallardó LM. What is the optimal level of vitamin D in non-dialysis chronic kidney disease population? World J Nephrol 2016; 5(5): 471-481
- URL: https://www.wjgnet.com/2220-6124/full/v5/i5/471.htm
- DOI: https://dx.doi.org/10.5527/wjn.v5.i5.471